Content area

|
|

Genomisk medicin som forbrugervare

Forfatter(e)
Lasse Folkersen & Thomas Werge
Institut for Biologisk Psykiatri, Psykiatrisk Center Sct. Hans, Region Hovedstadens Psykiatri

Ugeskr Læger 2019;181:V11180789
Reference: 
Ugeskr Læger 2019;181:V11180789
Blad nummer: 

Lasse Folkersen & Thomas Werge:

Genomic medicine as consumer goods

Ugeskr Læger 2019;181:V11180789

In this review, current trends in personal genetics are covered. The main differences between the “classic” rare high-effect mutations vs. the combined effects of thousands of common, low-risk variants are outlined, and then we provide examples of possible clinical use of microarray-based genetic measurements of rare high-risk mutations, and diagnosis-specific polygenic risk scores. The aim of this review is to discuss the possible clinical relevance vs. the hyped and potentially harmful overinterpretations of direct-to-consumer genetics services.

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Mats Lindberg | 22/01
1 Kommentar
af Thomas Birk Kristiansen | 22/01
2 kommentarer
af Lars Erik Bryld | 22/01
3 kommentarer
af Lasse Wissing Micheelsen | 20/01
3 kommentarer
af Thomas Sigurd Alber | 20/01
2 kommentarer
af Johan Ludvig Reventlow | 18/01
1 Kommentar
af Bjarne Skjødt Hjaltalin | 18/01
1 Kommentar